Visual assessment of [11C]PIB PET in patients with cognitive impairment

被引:27
|
作者
Suotunen, Timo [1 ]
Hirvonen, Jussi [1 ]
Immonen-Raiha, Pirjo [2 ]
Aalto, Sargo [1 ,3 ]
Lisinen, Irina [4 ]
Arponen, Eveliina [1 ]
Teras, Mika [1 ]
Koski, Kari [5 ]
Sulkava, Raimo [6 ,7 ]
Seppanen, Marko [1 ]
Rinne, Juha O. [1 ,2 ]
机构
[1] Turku PET Ctr, Turku 20521, Finland
[2] Turku Univ Hosp, FIN-20520 Turku, Finland
[3] Abo Akad Univ, Dept Psychol, Turku, Finland
[4] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland
[5] Salo Reg Hosp, Neurol Outpatient Dept, Salo, Finland
[6] Univ Kuopio, Sch Publ Hlth & Clin Nutr, Geriatr Unit, Kuopio, Finland
[7] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
基金
芬兰科学院;
关键词
Alzheimer's disease; PET; C-11-PIB; C-11-6-OH-BTA-1; Visual assessment; Amyloid imaging; VOXEL-BASED ANALYSIS; AMYLOID LIGAND; ALZHEIMERS-DISEASE; ATROPHY; HIPPOCAMPAL; DEPOSITION; F-18-FDG; DEMENTIA; BURDEN; MRI;
D O I
10.1007/s00259-010-1382-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to evaluate the visual assessment of positron emission tomography images of N-[methyl-11C]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole ([11C]PIB) in a patient population with mild to moderate memory impairment or dementia. We compared the visual ratings of two readers using kappa statistics and correlated the results of visual and quantitative region of interest (ROI) analyses. The one reader had good experience in evaluating PIB images and the other had little previous experience. The sensitivity and specificity of the visual assessment was determined using quantitative data from 18 healthy controls previously examined: [11C]PIB uptake was considered as abnormal if it was more than 2 SD above the mean of the healthy subjects. The evaluation of visual classification as "normal" or "abnormal" showed good interobserver agreement (kappa = 0.90). There was a clear correlation between visual and quantitative analysis (r = 0.47-0.79, p < 0.001). The most difficult visually assessed brain area was the putamen (kappa = 0.11; correlation with quantitative analysis: reader A r = 0.22; reader B r = 0.60). Our study shows that visual evaluation of [C-11]PIB images conforms with quantitative analyses also in a clinical patient population supporting the feasibility of visual evaluation in clinical settings.
引用
收藏
页码:1141 / 1147
页数:7
相关论文
共 50 条
  • [21] Clinically Different Stages of Alzheimer's Disease Associated by Amyloid Deposition with [11C]-PIB PET Imaging
    Hatashita, Shizuo
    Yamasaki, Hidetomo
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (03) : 995 - 1003
  • [22] PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB
    Faria, Daniele de Paula
    Copray, Sjef
    Sijbesma, Jurgen W. A.
    Willemsen, Antoon T. M.
    Buchpiguel, Carlos A.
    Dierckx, Rudi A. J. O.
    de Vries, Erik F. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 995 - 1003
  • [23] Advances in diagnosing mild cognitive impairment and Alzheimer's disease using 11C-PIB- PET/CT and common neuropsychological tests
    Zhao, Qing
    Du, Xinxin
    Chen, Wenhong
    Zhang, Ting
    Xu, Zhuo
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [24] A simple, versatile, low-cost and remotely operated apparatus for [11C]acetate, [11C]choline, [11C]methionine and [11C]PIB synthesis
    Cheung, Man-ki
    Ho, Chi-lai
    APPLIED RADIATION AND ISOTOPES, 2009, 67 (04) : 581 - 589
  • [25] Longitudinal Assessment o f Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer's Disease
    Hatashita, Shizuo
    Wakebe, Daichi
    Kikuchi, Yuki
    Ichijo, Atsushi
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [26] [18F]FDG, [11C]PiB, and [18F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline
    Okonkwo, David O.
    Puffer, Ross C.
    Minhas, Davneet S.
    Beers, Sue R.
    Edelman, Kathryn L.
    Sharpless, Jane
    Laymon, Charles M.
    Lopresti, Brian J.
    Benso, Steven
    Puccio, Ava M.
    Pathak, Sudhir
    Ikonomovic, Milos D.
    Mettenburg, Joseph M.
    Schneider, Walter
    Mathis, Chester A.
    Mountz, James M.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [27] Concordance Between Cerebrospinal Fluid Biomarkers and [11C] PIB PET in a Memory Clinic Cohort
    Zwan, Marissa
    van Harten, Argonde
    Ossenkoppele, Rik
    Bouwman, Femke
    Teunissen, Charlotte
    Adriaanse, Sofie
    Lammertsma, Adriaan
    Scheltens, Philip
    van Berckel, Bart
    van der Flier, Wiesje
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (03) : 801 - 807
  • [28] Multimodal analysis using [11C]PiB-PET/MRI for functional evaluation of patients with Alzheimer's disease
    Okazawa, Hidehiko
    Ikawa, Masamichi
    Jung, Minyoung
    Maruyama, Rikiya
    Tsujikawa, Tetsuya
    Mori, Tetsuya
    Rahman, Mahmudur G. M.
    Makino, Akira
    Kiyono, Yasushi
    Kosaka, Hirotaka
    EJNMMI RESEARCH, 2020, 10 (01)
  • [29] Investigation of 11C-PiB equivocal PET findings
    Hosokawa, Chisa
    Ishii, Kazunari
    Hyodo, Tomoko
    Sakaguchi, Kenta
    Usami, Kimio
    Shimamoto, Kenji
    Yamazoe, Yuzuru
    Hosono, Makoto
    Hanada, Kazushi
    Ueda, Masami
    Saigo, Kazuma
    Murakami, Takamichi
    ANNALS OF NUCLEAR MEDICINE, 2015, 29 (02) : 164 - 169
  • [30] Impact of spillover from white matter by partial volume effect on quantification of amyloid deposition with [11C]PiB PET
    Matsubara, Keisuke
    Ibaraki, Masanobu
    Shimada, Hitoshi
    Ikoma, Yoko
    Suhara, Tetsuya
    Kinoshita, Toshibumi
    Itco, Hiroshi
    NEUROIMAGE, 2016, 143 : 316 - 324